Cardiometabolic Disease Burden and Steroid Excretion in Benign Adrenal Tumors : A Cross-Sectional Multicenter Study.
Alessandro Prete, Anuradhaa Subramanian, Irina Bancos...
https://pubmed.ncbi.nlm.nih.gov/34978855/Actively Recruiting
Led by Chongqing Medical University · Updated on 2026-09-24
200
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are investigating the causes, development, diagnosis, and treatment of adrenogenic autonomic cortisol secretion ACS in Chinese adults. This condition often occurs alongside adrenal incidentalomas AI, which are commonly detected through advanced imaging technologies. While mild ACS MACS may lack typical Cushing syndrome symptoms and rarely progresses to overt Cushing, it is linked to higher risks of diabetes, hypertension, cardiovascular events, bone disease, and mortality compared to non-functional adenomas. Personalized treatment for MACS remains challenging, and prospective studies are needed to guide clinical decisions. The study prospectively includes patients with adrenal incidentalomas who show autonomic cortisol secretion based on a cortisol level greater than 50 nmolL after a 1 mg dexamethasone suppression test 1mg-DST. Participants are categorized into study and control groups depending on their 1mg-DST cortisol levels above or below this threshold. The research aims to evaluate adrenal function, develop tailored treatment strategies, and follow patients over time to assess prognosis. This approach will provide new evidence to standardize diagnosis and management of ACS. Participants will undergo assessments including PET-CT scans to measure SUVmax values over a 10-year period. Researchers will also study the etiology and pathogenesis of ACS during this time. Data collection involves clinical evaluations, endocrine function tests, and ongoing follow-up to monitor outcomes and complications. The long-term observation aims to improve understanding of ACS and inform personalized care for patients with adrenal incidentalomas.
CONDITIONS
Chongqing Adrenogenic Autonomic Cortisol Secretion Cohort Study
Q
Qifu Li, PhD
S
Shumin Yang, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Chongqing Medical University
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 10 years
Participants undergo clinical assessments, imaging tests including PET-CT scans, and endocrine function evaluations over time to monitor adrenal function and disease progression.
Regular visits as scheduled during follow-up
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Alessandro Prete, Anuradhaa Subramanian, Irina Bancos...
https://pubmed.ncbi.nlm.nih.gov/34978855/Timo Deutschbein, Giuseppe Reimondo, Guido Di Dalmazi...
https://pubmed.ncbi.nlm.nih.gov/35533704/Ying Jing, Jinbo Hu, Rong Luo...
https://pubmed.ncbi.nlm.nih.gov/36095315/Chongqing Medical University
Lead Sponsor